Supply Chain

(Image: Getty/rawpixel)

Digoxin API supply secured through acquisition

By Maggie Lynch

C2 Pharma acquires digoxin API product portfolio from Noblius to secure supply of the ingredient, after disruption of the supply of the API for a number of years.

(Image: Getty/Oatawa)

Almac expands neo-antigen peptide manufacturing

By Maggie Lynch

Almac announced it has increased its supply of neo-antigen peptides for individualized cancer treatments with the addition of another stream of GMP manufacturing.

(Image: Getty/Andrey Bukreev)

Looking to the future of a safe supply chain

By Ben Hargreaves

in-PharmaTechnologist (IPT) speaks to Ettore Cucchetti (EC), CEO of ACGI, about how the biopharma industry is adapting to the threat of counterfeit medicine and how he expects the industry will adopt further measures beyond those stipulated in the EU...